B2011-12240_AU Reagent Quick Reference Guide_US.indd

BR-13648B Not for distribution outside of the U.S.

Blood Banking

Centrifugation

Chemistry

Flow Cytometry

Hematology

Hemostasis

Immunoassay

Information Systems

Lab Automation

Molecular Diagnostics

Rapid Diagnostics

AU reagent quick reference guide. Reliable results, enhanced productivity.

AU Chemistry Systems

The precision specifi cations for the AU reagents listed in this document represent the

minimum levels of performance the tests are designed to meet for total precision.

These specifi cations do not represent typical performance, except where indicated.

However, typical performance is signifi cantly better.

The measuring points listed in this document are the photometric time points the software

uses to calculate a result for each assay.

If you require additional information regarding any of the assays, please consult each

individual chemistry’s Instructions for Use (IFU) and analyzer-specifi c setting sheet.

Table of Contents

General ChemistryAlanine Aminotransferase (ALT) ...........................................................4Albumin (ALB) ...........................................................................................4Alkaline Phosphatase (ALP) ..................................................................4Amylase (AMY) .........................................................................................5Aspartate Aminotransferase (AST)......................................................5Bicarbonate (CO2) ..................................................................................5Calcium Arsenazo (CALA) .....................................................................6Calcium oCPC (CA) ................................................................................6Chloride (CL) .............................................................................................6Cholesterol (CHOL) ................................................................................7Creatinine (CRE) ......................................................................................7Creatine Kinase (CK) ..............................................................................7Direct Bilirubin (DBIL) .............................................................................8 Gamma-Glutamyltransferase (GGT)...................................................8 Glucose (GLU) ..........................................................................................9HDL Cholesterol (HDL-C) .....................................................................9Iron (IRON) .................................................................................................9LDL Cholesterol (LDL-C) .................................................................... 10Lactate Dehydrogenase (IFCC) (LDH)............................................ 10Lipase (LIP) ............................................................................................. 10Magnesium (MG) ....................................................................................11Phosphorus, Inorganic (PHOS) .........................................................11Potassium (K) ..........................................................................................11Sodium (NA) ............................................................................................12Total Bilirubin (TBIL) ..............................................................................12Total Protein (TP) ....................................................................................12Triglyceride (TRIG) ................................................................................ 13Unsaturated Iron Binding Capacity (UIBC) .................................... 13Urea Nitrogen (BUN) ............................................................................ 13Uric Acid (UA) .........................................................................................14Urinary/CSF Protein (UCSFP) ............................................................14

Proteins/SerologyAlpha-1-Acidglycoprotein (AAG) ...................................................... 15Alpha-1-Antitrypsin (AAT) ................................................................... 15Anti-Streptolysin O (ASO) .................................................................. 15Apolipoprotein A1 (APO A1) .............................................................. 16Apolipoprotein B (APO B) .................................................................. 16Beta-2 Microglobulin (B2M) ............................................................... 16Ceruloplasmin (CER) ............................................................................17Complement 3 (C3) ...............................................................................17Complement 4 (C4) ...............................................................................17C-Reactive Protein (CRP) .................................................................. 18C-Reactive Protein (CRPN) .............................................................. 18C-Reactive Protein, High Sensitivity (CRPHS) ............................. 18Ferritin (FERR) ....................................................................................... 19Haptoglobin (HAPT) ............................................................................. 19Immunoglobulin A (IGA) ...................................................................... 19Immunoglobulin G (IGG) ..................................................................... 20Immunoglobulin M (IGM) ..................................................................... 20Microalbumin (MALB) .......................................................................... 20Prealbumin (PALB)................................................................................ 21Rheumatoid Factor (RF) ...................................................................... 21Transferrin (TRF) .................................................................................... 21

EsotericsAmmonia (AMMON) ............................................................................. 22Cholinesterase (CHE) .......................................................................... 22Creatine Kinase MB (CKMB) ............................................................. 22Hemoglobin A1c (IFCC) (HBA1C).................................................... 23Lactate (LAC) ......................................................................................... 23Lithium (LI) ............................................................................................... 23

ThyroidsThyroxine (T4) ......................................................................................... 24T-Uptake (TUP) ...................................................................................... 24

Therapeutic Drug Monitoring (TDM)Acetaminophen (ACETA) .................................................................... 25Amikacin (AMIK) .................................................................................... 25Caffeine (CAFF) .................................................................................... 25Carbamazepine (CARB) ...................................................................... 26Digoxin (DIG) .......................................................................................... 26Disopyramide (DISO) ........................................................................... 26Ethosuximide (SUXI) ............................................................................. 27Gentamicin (GENT) .............................................................................. 27Lidocaine (LIDO) ................................................................................... 27Methotrexate (MTRX) ........................................................................... 28N-Acetylprocainamide (NAPA) .......................................................... 28Phenobarbital (PBARB)....................................................................... 28Phenytoin (PHENY) .............................................................................. 29Primidone (PRIM) .................................................................................. 29Procainamide (PROC) ......................................................................... 29Quinidine (QUIN) .................................................................................. 30Salicylic Acid (SALI) ............................................................................. 30Theophylline (THEO) ............................................................................ 30Tobramycin (TOB) ................................................................................. 31Valproic Acid (VPA) .............................................................................. 31Vancomycin (VANC) ............................................................................. 31

Drugs of Abuse Testing (DAT)Amphetamines 300ng (AMPH+) ...................................................... 32Amphetamines 500ng (AMPH+) ...................................................... 32Amphetamines 1000ng (AMPH+) .................................................... 32Amphetamines 300ng SQ (AMPH+) .............................................. 33Amphetamines 500ng SQ (AMPH+)............................................... 33Amphetamines 1000ng SQ (AMPH+) ............................................ 33Barbiturate 200ng (BARB+) .............................................................. 34Barbiturate 300ng (BARB+) .............................................................. 34Barbiturate SQ (BARB+) .................................................................... 34Barbiturate, Tox (TBARB) .................................................................... 35Benzodiazepine 200ng (BENZ+) ...................................................... 35Benzodiazepine 300ng (BENZ+) ...................................................... 35Benzodiazepine SQ (BENZ+) ............................................................ 36Benzodiazepine, Tox (TBENZ) ........................................................... 36Cannabinoid 20ng (THC) ................................................................... 36Cannabinoid 50ng (THC) ................................................................... 37Cannabinoid 100ng (THC) ................................................................. 37Cannabinoid SQ (THC) ....................................................................... 37Cocaine Metabolite 150ng (COCA+) ............................................. 38Cocaine Metabolite 300ng (COCA+) ............................................. 38Cocaine Metabolite SQ (COCA+) ................................................... 38Creatinine, Tox (CRTOX) ..................................................................... 39Ecstasy 300ng (XTC) .......................................................................... 39Ecstasy 500ng (XTC) .......................................................................... 39Ecstasy 300ng SQ (XTC) ................................................................... 40Ecstasy 500ng SQ (XTC) ................................................................... 40Ethyl Alcohol (ETOH+) ........................................................................ 40LSD (LSD) ................................................................................................41LSD SQ (LSD) ........................................................................................41Methadone 150ng (METH+) ...............................................................41Methadone 300ng (METH+) .............................................................. 42Methadone SQ (METH+) .................................................................... 42Methaqualone (METQ+) ...................................................................... 42Methaqualone SQ (METQ+) .............................................................. 43Opiates 300ng (OPIA+) ...................................................................... 43Opiates 2000ng (OPIA+) ................................................................... 43Opiates 300ng SQ (OPIA+) .............................................................. 44Opiates 2000ng SQ (OPIA+)............................................................ 44Oxycodone 100ng (OXY) ................................................................... 44Oxycodone 300ng (OXY) ................................................................... 45Oxycodone SQ (OXY) ......................................................................... 45Phencyclidine (PCP+).......................................................................... 45Phencyclidine SQ (PCP+) .................................................................. 46Propoxyphene (PPX+) .......................................................................... 46Propoxyphene SQ (PPX+) .................................................................. 46Tricyclics, Tox (TRICY) ......................................................................... 47

4

General Chemistry

Chemistry Name Alanine Aminotransferase

(IFCC) Albumin

Alkaline Phosphatase

(IFCC)

Chemistry Abbreviation ALT ALB ALP

Measurement Principle UV/NADH BCG p-Nitro-phenylphosphate

Reaction Type Rate End Rate

Primary Wavelength 340 nm 600 nm 410 nm

Measuring Points 14, 27 0, 1 13, 19 (AU400/AU600/AU640)

16, 27 (AU480/AU680/AU2700/

AU5400)

Sample Type Serum/Plasma Serum/Plasma Serum/Plasma

Sample Size (AU400/AU600/AU640)

Serum/Plasma 10 μL 2 μL 3 μL

Urine N/A N/A N/A

CSF N/A N/A N/A

Sample Size (AU480/AU680/

AU2700/AU5400)

Serum/Plasma 5 μL 1.6 μL 1.8 μL

Urine N/A N/A N/A

CSF N/A N/A N/A

Reference Interval SI Units SI Units SI Units

Serum/Plasma 7-52 IU/L 0.11-0.87 μkat/L 3.5-5.7 g/dL 35-57 g/L 34-104 IU/L 0.57-1.78 μkat/L

Urine N/A N/A N/A N/A N/A N/A

CSF N/A N/A N/A N/A N/A N/A

Analytical Range SI Units SI Units SI Units

Serum/Plasma 3-500 IU/L 0.05-8.33 μkat/L 1.5-6.0 g/dL 15-60 g/L 5-1500 IU/L 0.1-25.0 μkat/L



Precision Specification SI Units SI Units SI Units

Serum/Plasma < 10% CV < 10% CV < 3% CV < 3% CV < 10% CV < 10% CV



Reagent Volume

AU400/AU600/AU640 R1 = 100 μL, R2 = 50 μL R1 = 58 μL R1 = 60 μL, R2 = 60 μL

AU480/AU680/AU2700/AU5400 R1 = 50 μL, R2 = 25 μL R1 = 46 μL R1 = 36 μL, R2 = 36 μL

Cartridge Part Number/Size

AU400/AU600/AU640 OSR6107 (4 x 500 tests) OSR6102 (4 x 500 tests)

OSR6202 (4 x 910 tests)

OSR6004 (4 x 170 tests)

OSR6104 (4 x 485 tests)

OSR6204 (4 x 840 tests)

AU480/AU680/AU2700/AU5400 OSR6107 (4 x 980 tests)

OSR6607 (4 x 3070 tests)†

OSR6102 (4 x 620 tests)

OSR6202 (4 x 1120 tests)

OSR6602 (4 x 3590 tests)†

OSR6004 (4 x 310 tests)

OSR6104 (4 x 820 tests)

OSR6204 (4 x 1450 tests)

OSR6504 (4 x 2510 tests)†

Liquid or Lyophilized Liquid Liquid Liquid

On-Instrument Stability 30 days 90 days 14 days

Storage Temperature +2 to +8°C +2 to +25°C +2 to +8°C

Calibration Frequency N/A 30 days N/A

Reagent Blank Frequency 7 days 30 days 14 days

Compatible Anticoagulants Heparin

EDTA1

Heparin

EDTA

Heparin

Calibrator Part Number N/A DR0070-2 N/A

Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS

Control Part Number N/A N/A N/A

Comment(s) † AU2700/AU5400 only1 Plasma should be multiplied by 1.02

† AU2700/AU5400 only † AU680/AU2700/AU5400 only

5

General Chemistry

Chemistry Name AmylaseAspartate Aminotransferase

(IFCC)Bicarbonate

Chemistry Abbreviation AMY AST CO2

Measurement Principle CNPG3 UV/NADH Phosphoenolpyruvate Carboxylase

Reaction Type Rate Rate Fixed


Measuring Points 5, 10 14, 27 1, 9

Sample Type Serum/Plasma/Urine Serum/Plasma Serum/Plasma



Urine 2 μL N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 1.6 μL 5 μL 2.5 μL

Urine 1.6 μL N/A N/A

CSF N/A N/A N/A


Serum/Plasma 29-103 U/L 0.48-1.72 μkat/L 13-39 U/L 0.22-0.65 μkat/L 21-31 mEq/L 21-31 mmol/L

Urine 5-27 U/hour 0.08-0.45 μkat/L N/A N/A N/A N/A



Serum/Plasma 10-2000 U/L 0.2-33.3 μkat/L 3-1000 U/L 0.05-16.7 μkat/L 2-45 mEq/L 2-45 mmol/L

Urine 10-1500 U/L 0.1-25 μkat/L N/A N/A N/A N/A



Serum/Plasma < 10% CV < 10% CV < 10% CV < 10% CV < 7% CV or SD

< 1.5 mEq/L1

< 7% CV or SD

< 1.5 mmol/L1

Urine < 10% CV < 10% CV N/A N/A N/A N/A


Reagent Volume

AU400/AU600/AU640 R1 = 200 μL R1 = 50 μL, R2 = 50 μL R1 = 50 μL

AU480/AU680/AU2700/AU5400 R1 = 160 μL R1 = 25 μL, R2 = 25 μL R1 = 42 μL


AU400/AU600/AU640 OSR6006 (4 x 50 tests)

OSR6106 (4 x 200 tests)

OSR6109 (4 x 500 tests)

OSR6209 (4 x 1000 tests)

OSR6137 (4 x 500 tests)

OSR6237 (4 x 1000 tests)


OSR6106 (4 x 240 tests)

OSR6109 (4 x 980 tests)

OSR6209 (4 x 1960 tests)

OSR6509 (4 x 3700 tests)†

OSR6137 (4 x 580 tests)

OSR6237 (4 x 1160 tests)

OSR6537 (4 x 2285 tests)†




Calibration Frequency N/A N/A 1 day

Reagent Blank Frequency 7 days 7 days 1 day

Compatible Anticoagulants Heparin Heparin Heparin

Calibrator Part Number N/A N/A DR0070 (1&2)

Control Name Serum/Plasma: Bio-Rad*/MAS

Urine: No specific recommendation

Bio-Rad*/MAS Bio-Rad*/MAS


Comment(s) † AU680/AU2700/AU5400 only 1 Use the greater number

† AU680/AU2700/AU5400 only

6

General Chemistry

Chemistry Name Calcium Arsenazo Calcium oCPC Chloride

Chemistry Abbreviation CALA CA CL

Measurement Principle Arsenazo o-Cresolphthalein Complexone ISE - Oriented PVC Membrane

Reaction Type End End N/A

Primary Wavelength 660 nm 570 nm N/A

Measuring Points 0, 10 0, 27/0, 10 N/A

Sample Type Serum/Plasma/Urine Serum/Urine Serum/Plasma/Urine


Serum/Plasma 3.5 μL 5 μL 20 μL

Urine 2 μL 2 μL 25 μL

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 2.5 μL 3.7 μL 20 μL


CSF N/A N/A N/A


Serum/Plasma 8.6-10.3 mg/dL 2.1-2.6 mmol/L 8.6-10.2 mg/dL 2.1-2.6 mmol/L 98-107 mEq/L 98-107 mmol/L

Urine 100-300 mg/24

hrs

25-75 mmol/24

hrs

100-300 mg/24

hrs

25-75 mmol/24

hrs

110-250 mEq/24

hrs

110-250 mmol/24

hrs



Serum/Plasma 4-18 mg/dL 1-4.5 mmol/L 0-18 mg/dL 0-4.5 mmol/L 50-200 mEq/L 50-200 mmol/L

Urine 0.1-40.0 mg/dL 0.025-10 mmol/L 0-40 mg/dL 0-10 mmol/L 15-400 mEq/L 15-400 mmol/L



Serum/Plasma < 5% CV < 5% CV < 5% CV or SD

< 0.33 mg/dL1

< 5% CV or SD

< 0.08 mmol/L1

< 5% CV < 5% CV

Urine < 5% CV or SD

< 0.33 mg/dL1

< 5% CV or SD

< 0.08 mmol/L1

< 5% CV < 5% CV


Reagent Volume

AU400/AU600/AU640 Serum: R1 = 29 μL

Urine: R1 = 25 μL

R1 = 60 μL, R2 = 60 μL N/A

AU480/AU680/AU2700/AU5400 Serum: R1 = 21 μL

Urine: R1 = 25 μL

Serum: R1 = 45 μL, R2 = 45 μL

Urine: R1 = 60 μL, R2 = 60 μL

N/A



OSR61117 (4 x 930 tests)

OSR6113 (4 x 450 tests)

OSR6213 (4 x 815 tests)

MU9196 (40000 tests/electrode)


OSR61117 (4 x 1300 tests)

OSR65117 (4 x 4500 tests)†

OSR6113 (4 x 590 tests)

OSR6213 (4 x 1080 tests)


Liquid or Lyophilized Liquid Liquid N/A

On-Instrument Stability 90 days 30 days 6 months (electrode)

90 days (reagents)


Calibration Frequency 30 days 1 day 1 day

Reagent Black Frequency 30 days 1 day N/A

Compatible Anticoagulants Heparin N/A Lithium Heparin

Ammonium Heparin

Calibrator Part Number Serum/Plasma: DR0070 (1&2)

Urine: DR0090

Serum/Plasma: DR0070 (1&2)

Urine: DR0090

Serum Low and High Standards:

AUH1014, AUH1015

Urine Low and High Standards:

AUH1016



Serum/Plasma: Bio-Rad*/MAS





Comment(s) † AU680/AU2700/AU5400 only 1 Use the greater number Reagents: AUH1011 Buffer

AUH1012 Mid-Standard

AUH1013 Reference

7

General Chemistry

Chemistry Name Cholesterol Creatinine Creatine Kinase

Chemistry Abbreviation CHOL CRE CK

Measurement Principle Enzymatic Modified Jaffe, Kinetic IFCC-CK (NAC)

Reaction Type End Fixed Rate



Sample Type Serum/Plasma Serum/Plasma/Urine Serum/Plasma



Urine N/A 8 μL N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 1.6 μL 8 μL 2.5 μL

Urine N/A 8 μL N/A

CSF N/A N/A N/A


Serum/Plasma < 200 mg/dL < 5.18 mmol/L M: 0.7-1.3 mg/dL

F: 0.6-1.2 mg/dL

M: 62-115

μmol/L

F: 53-106 μmol/L

30-223 U/L 0.50-3.72 μkat/L

Urine N/A N/A M: 14-26 mg/

kg/24 hrs

F: 11-20 mg/

kg/24 hrs

N/A N/A N/A



Serum/Plasma 25-700 mg/dL 0.6-18.1 mmol/L 0.2-25.0 mg/dL 18-2210 μmol/L 10-2000 U/L 0.17-33.3 μkat/L

Urine N/A N/A 1-300 mg/dL 88-26520 μmol/L N/A N/A




Urine N/A N/A N/A N/A


Reagent Volume

AU400/AU600/AU640 R1 = 45 μL R1 = 120 μL, R2 = 120 μL R1 = 120 μL, R2 = 30 μL

AU480/AU680/AU2700/AU5400 R1 = 24 μL Serum: R1 = 48 μL, R2 = 48 μL

Urine: R1 = 120 μL, R2 = 120 μL

R1 = 100 μL, R2 = 25 μL



OSR6216 (4 x 1000 tests)

OSR6178 (4 x 420 tests) OSR6179 (4 x 200 tests)

OSR6279 (4 x 425 tests)


OSR6216 (4 x 1830 tests)

OSR6516 (4 x 3975 tests)†

OSR6178 (4 x 990 tests)

OSR6678 (4 x 3070 tests)†

OSR6179 (4 x 230 tests)

OSR6279 (4 x 490 tests)




Calibration Frequency 30 days 1 day N/A

Reagent Blank Frequency 30 days 1 day 30 days

Compatible Anticoagulants EDTA

Heparin

Heparin Heparin

Calibrator Part Number DR0070-2 Serum/Plasma: DR0070 (1&2)

Urine: DR0091

N/A

Control Name Bio-Rad*/MAS Serum/Plasma: Bio-Rad*/MAS


Bio-Rad*/MAS


Comment(s) † AU680/AU2700/AU5400 only † AU2700/AU5400 only

8

General Chemistry

Chemistry Name Direct Bilirubin Direct Bilirubin Gamma-Glutamyltransferase

Chemistry Abbreviation DBIL1 DBIL GGT

Measurement Principle Diazonium Salt, DPD Diazonium Salt, DPD Glutamyl-carboxy-p-nitroanilide

Reaction Type End End Rate


Measuring Points 0, 2 0, 12/0, 10 14, 23 (AU400/AU600/AU640)

16, 23 (AU480/AU680/AU2700/

AU5400)

Sample Type Serum/Plasma Serum Serum/Plasma



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 0.03-0.18 mg/dL 0.51-3.08 μmol/L 0.0-0.2 mg/dL 0-3.42 μmol/L 9-64 U/L 0.15-1.07 μkat/L




Serum/Plasma 0-10 mg/dL 0-171 μmol/L 0.05-10 mg/dL 0.9-171 μmol/L 3-1200 U/L 0.05-20 μkat/L




Serum/Plasma < 5% CV or SD

≤ 0.07 mg/dL2

< 5% CV or SD

≤ 1.2 μmol/L2

< 8% CV or SD

≤ 0.21 mg/dL1

< 8% CV or SD

≤ 3.6 μmol/L1

< 10% CV < 10% CV



Reagent Volume

AU400/AU600/AU640 R1 = 30 μL R1 = 150 μL, R2 = 30 μL R1 = 75 μL, R2 = 75 μL

AU480/AU680/AU2700/AU5400 R1 = 25 μL R1 = 125 μL, R2 = 25 μL R1 = 50 μL, R2 = 50 μL



OSR6211 (4 x 660 tests)


OSR6219 (4 x 660 tests)


OSR6211 (4 x 660 tests)

OSR6511 (4 x 3835 tests)†


OSR6219 (4 x 980 tests)




Calibration Frequency 7 days 21 days N/A


Compatible Anticoagulants Heparin Heparin EDTA

Calibrator Part Number DR0070-1 DR0070-1 N/A



Comment(s) 1 Both a color test DBIL-C and blank

test DBIL-B need to be run2 Use the greater number

† AU680/AU2700/AU5400 only

1 Use the greater number

9

General Chemistry

Chemistry Name Glucose HDL Cholesterol Iron

Chemistry Abbreviation GLU HDL-C IRON

Measurement Principle Hexokinase-UV/NAD Accelerator Selective Detergent TPTZ

Reaction Type End End End


Measuring Points 0, 27/0, 10 0, 27/0, 10 0, 12/0, 10

Sample Type Serum/Plasma/Urine/CSF Serum/Plasma Serum/Plasma



Urine 3 μL N/A N/A

CSF 2 μL N/A N/A


AU2700/AU5400)


Urine 3 μL N/A N/A

CSF 1.6 μL N/A N/A


Serum/Plasma 70-105 mg/dL 3.9-5.8 mmol/L 23-92 mg/dL 0.59-2.38 mmol/L 50-212 μg/dL 8.9-37.9 μmol/L


CSF 40-70 mg/dL 2.2-3.9 mmol/L N/A N/A N/A N/A


Serum/Plasma 10-800 mg/dL 0.6-44.4 mmol/L 2.5-200 mg/dL 0.07-5.17 mmol/L 10-1000 μg/dL 1.8-178.6 μmol/L

Urine 10-700 mg/dL 0.6-39 mmol/L N/A N/A N/A N/A

CSF 10-800 mg/dL 0.6-44.4 mmol/L N/A N/A N/A N/A





Reagent Volume

AU400/AU600/AU640 R1 = 50 μL, R2 = 25 μL R1 = 200 μL, R2 = 66 μL R1 = 50 μL, R2 = 50 μL

AU480/AU680/AU2700/AU5400 Serum: R1 = 40 μL, R2 = 20 μL

Urine: R1 = 50 μL, R2 = 25 μL

R1 = 200 μL, R2 = 66 μL R1 = 30 μL, R2 = 30 μL



OSR6221 (4 x 1035 tests)

OSR6195 (4 x 150 tests)

OSR6295 (4 x 250 tests)

OSR6186 (4 x 300 tests)

OSR6286 (4 x 595 tests)


OSR6221 (4 x 1300 tests)

OSR6621 (4 x 3755 tests)†

OSR6195 (4 x 150 tests)

OSR6295 (4 x 250 tests)

OSR6186 (4 x 500 tests)

OSR6286 (4 x 970 tests)




Calibration Frequency 30 days 7 days 30 days



Heparin

Sodium Fluoride

EDTA

Heparin

Heparin

Calibrator Part Number Serum/Plasma: DR0070-2

Urine: DR0090

ODC0023 DR0070-1



Bio-Rad*/MAS Bio-Rad*/MAS


Comment(s) † AU2700/AU5400 only

10

General Chemistry

Chemistry Name LDL CholesterolLactate Dehydrogenase

(IFCC)Lipase

Chemistry Abbreviation LDL-C LDH LIP

Measurement Principle Liquid Selective Detergent Lactate-Pyruvate (NAD); IFCC Enzymatic, Colorimetric

Reaction Type End Rate Rate


Measuring Points 0, 27/0, 10 14, 21 (AU400/AU640)

15, 23 (AU480/AU680/AU2700/

AU5400)

17, 27




Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 75-193 mg/dL 1.9-5.0 mmol/L 140-271 U/L 2.3-4.5 μkat/L 11-82 U/L 0.18-1.37 μkat/L




Serum/Plasma 7.0-400 mg/dL 0.2-10.3 mmol/L 25-1200 U/L 0.4-20.0 μkat/L 3-600 U/L 0.05-10 μkat/L







Reagent Volume


AU480/AU680/AU2700/AU5400 R1 = 200 μL, R2 = 66 μL R1 = 62 μL, R2 = 31 μL R1 = 144 μL, R2 = 48 μL



OSR6296 (4 x 250 tests)

OSR6127 (4 x 500 tests)

OSR6227 (4 x 625 tests)

OSR6130 (4 x 45 tests)

OSR6230 (4 x 150 tests)


OSR6296 (4 x 250 tests)

OSR6127 (4 x 640 tests)

OSR6227 (4 x 800 tests)

OSR6130 (4 x 45 tests)

OSR6230 (4 x 180 tests)

Liquid or Lyophilized Liquid Liquid Lyophilized



Calibration Frequency 7 days N/A 7 days



Heparin

Heparin Heparin

Calibrator Part Number ODC0024 N/A Included



Comment(s)

11

General Chemistry

Chemistry Name MagnesiumPhosphorus

(Inorganic)Potassium

Chemistry Abbreviation MG PHOS K

Measurement Principle Xylidyl Blue Phosphomolybdate Complex ISE - Crown-Ether Membrane

Reaction Type End End N/A

Primary Wavelength 520 nm 340 nm N/A

Measuring Points 0, 27 (AU400/AU600/AU640)

0, 10 (AU480/AU680/AU2700/AU5400)

0, 27/0, 10 N/A

Sample Type Serum/Plasma/Urine Serum/Urine Serum/Plasma/Urine



Urine 2 μL 3 μL of a 1/10 20 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine 2 μL 3 μL of a 1/10 20 μL

CSF N/A N/A N/A


Serum/Plasma 1.9-2.7 mg/dL 0.78-1.11 mmol/L 3.7-7.2 mg/dL 1.2-2.3 mmol/L 3.5-5.1 mEq/L 3.5-5.1 mmol/L

Urine 24-255 mg/24 hrs 2-21.2 mEq/24 hrs 0.3-1.3 g/24 hrs 9.7-42 mmol/24 hrs 25-125 mEq/

24 hrs

25-125 mmol/

24 hrs



Serum/Plasma 0.5-8.0 mg/dL 0.2-3.3 mmol/L 1-20 mg/dL 0.3-6.5 mmol/L 1-10 mEq/L 1-10 mmol/L

Urine 0.5-10.0 mg/dL 0.2-4.1 mmol/L 10-200 mg/dL 3.2-64.5 mmol/L 2-200 mEq/L 2-200 mmol/L




Urine N/A N/A < 5% CV < 5% CV


Reagent Volume

AU400/AU600/AU640 R1 = 200 μL R1 = 30 μL, R2 = 30 μL N/A

AU480/AU680/AU2700/AU5400 Serum: R1 = 160 μL

Urine: R1 = 200 μL

Serum: R1 = 25 μL, R2 = 25 μL

Urine: R1 = 30 μL, R2 = 30 μL

N/A

Cartridge/Kit Size

AU400/AU600/AU640 OSR6189 (4 x 200 tests) OSR6122 (4 x 500 tests)

OSR6222 (4 x 1330 tests)


AU480/AU680/AU2700/AU5400 OSR6189 (4 x 250 tests) OSR6122 (4 x 590 tests)

OSR6222 (4 x 1570 tests)


Liquid or Lyophilized Liquid Liquid N/A

On-Instrument Stability 7 days 30 days 6 months (electrode)

90 days (reagents)


Calibration Frequency 7 days 30 days 1 day

Reagent Blank Frequency 1 day 30 days N/A

Compatible Anticoagulants Heparin N/A Lithium Heparin

Ammonium Heparin


Urine: DR0090

Serum/Plasma: DR0070-2

Urine: DR0090

Serum Low and High Standards:

AUH1014, AUH1015


AUH1016





Bio-Rad*/MAS


Comment(s) Reagents: AUH1011 Buffer


AUH1013 Reference

12

General Chemistry

Chemistry Name Sodium Total Bilirubin Total Protein

Chemistry Abbreviation NA TBIL1 TP

Measurement Principle ISE - Crown-Ether Membrane Diazonium Salt, DPD Biuret; Blanked

Reaction Type N/A End End

Primary Wavelength N/A 570 nm 540 nm

Measuring Points N/A 0, 10 0, 27/0, 10

Sample Type Serum/Plasma/Urine Serum/Plasma Serum


Serum/Plasma 20 μL 6 μL 3.0 μL (AU400)/6.0 μL

Urine 20 μL N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine 20 μL N/A N/A

CSF N/A N/A N/A


Serum/Plasma 136-145 mEq/L 136-145 mmol/L 0.3-1.0 mg/dL 5.1-17.1 μmol/L 6.4-8.9 g/dL 64-89 g/L

Urine 40-220 mEq/24

hrs

40-220 mmol/24

hrs

N/A N/A N/A N/A



Serum/Plasma 50-200 mEq/L 50-200 mmol/L 0-30 mg/dL 0-513 μmol/L 3-12 g/dL 30-120 g/L

Urine 10-400 mEq/L 10-400 mmol/L N/A N/A N/A N/A



Serum/Plasma < 5% CV < 5% CV < 5% CV or SD

≤ 0.10 mg/dL2

< 5% CV or SD

≤ 1.7 μmol/L2

< 4% CV < 4% CV

Urine < 5% CV < 5% CV N/A N/A N/A N/A


Reagent Volume

AU400/AU600/AU640 N/A R1 = 30 μL R1 = 50 μL, R2 = 50 μL

AU480/AU680/AU2700/AU5400 N/A R1 = 26 μL R1 = 33 μL, R2 = 33 μL


AU400/AU600/AU640 MU9194 (40000 tests/electrode) OSR6112 (4 x 500 tests)

OSR6212 (4 x 1300 tests)

OSR6132 (4 x 500 tests)

OSR6232 (4 x 960 tests)

AU480/AU680/AU2700/AU5400 MU9194 (40000 tests/electrode) OSR6112 (4 x 590 tests)

OSR6212 (4 x 1570 tests)

OSR6512 (4 x 3465 tests)†

OSR6132 (4 x 750 tests)

OSR6232 (4 x 1440 tests)

OSR6632 (4 x 4255 tests)†

Liquid or Lyophilized N/A Liquid Liquid

On-Instrument Stability 6 months (electrode)

90 days (reagents)

90 days 30 days


Calibration Frequency 1 day 30 days As needed

Reagent Blank Frequency N/A 30 days As needed

Compatible Anticoagulants Lithium Heparin

Ammonium Heparin

EDTA

Heparin

Heparin

Calibrator Part Number Serum Low and High Standards:

AUH1014, AUH1015


AUH1016

DR0070-1 DR0070-2



Comment(s) Reagents: AUH1011 Buffer


AUH1013 Reference

1 Both a color test TBIL-C and blank test

TBIL-B need to be run2 Use the greater number

† AU680/AU2700/AU5400 only

† AU2700/AU5400 only

13

General Chemistry

Chemistry Name Triglyceride Unsaturated Iron Binding Capacity Urea Nitrogen

Chemistry Abbreviation TRIG UIBC BUN

Measurement Principle Glycerol Phosphate Oxidase Nitroso-PSAP Urease GLDH

Reaction Type End End Rate


Measuring Points 0, 27/0, 10 0, 27/0, 10 12, 18

Sample Type Serum/Plasma Serum/Plasma Serum/Plasma/Urine


Serum/Plasma 2 μL 10 μL 2.5 μL

Urine N/A N/A 3 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A 2 μL

CSF N/A N/A N/A


Serum/Plasma < 150 mg/dL < 1.7 mmol/L 155-355 μg/dL 27.7-63.4 μmol/L 7-25 mg/dL 2.5-8.9 mmol/L

Urine N/A N/A N/A N/A 7-16 g/24 hrs 250-571 mmol/24

hrs



Serum/Plasma 10-1000 mg/dL 0.1-11.3 mmol/L 55-450 μg/dL 9.8-80.4 μmol/L 2-130 mg/dL 0.7-46.4 mmol/L

Urine N/A N/A N/A N/A 20-1300 mg/dL 7-464 mmol/L






Reagent Volume

AU400/AU600/AU640 R1 = 120 μL, R2 = 25 μL R1 = 150 μL, R2 = 30 μL1 R1 = 50 μL, R2 = 50 μL

AU480/AU680/AU2700/AU5400 R1 = 66 μL, R2 = 17 μL R1 = 120 μL, R2 = 24 μL1 R1 = 40 μL, R2 = 40 μL



OSR61118 (4 x 500 tests)


OSR6234 (4 x 935 tests)


OSR61118 (4 x 735 tests)

OSR66118 (4 x 2530 tests)†


OSR6234 (4 x 1230 tests)

OSR6634 (4 x 4115 tests)†







Heparin

Heparin EDTA

Lithium Heparin

Sodium Heparin

Calibrator Part Number DR0070-2 DR0070-2 Serum/Plasma: DR0070-2

Urine: DR0090



Comment(s) † AU2700/AU5400 only 1 Transfer R1a into R1 and R2a into R2 † AU2700/AU5400 only

14

General Chemistry

Chemistry Name Uric Acid Urinary/CSF Protein

Chemistry Abbreviation UA UCSFP

Measurement Principle Uricase Pyrogallol Red

Reaction Type End End

Primary Wavelength 660 nm 600 nm

Measuring Points 0, 27/0, 10 0, 10

Sample Type Serum/Plasma/Urine Urine/CSF


Serum/Plasma 7 μL N/A

Urine 2 μL 2 μL

CSF N/A 2 μL


AU2700/AU5400)

Serum/Plasma 5.6 μL N/A

Urine 1.6 μL 1.6 μL

CSF N/A 1.6 μL

Reference Interval SI Units SI Units

Serum/Plasma 2.3-7.6 mg/dL 137-452 μmol/L N/A N/A

Urine 250-800 mg/24

hrs

1488-4760

μmol/24 hrs

50-80 mg/24 hrs

at rest

0.05-0.8 g/24 hrs

at rest

CSF N/A N/A Adults: 15-45

mg/dL

Newborns < 1

month: 15-130

mg/dL

Adults: 0.15-0.45

g/L

Newborns < 1

month: 0.15-1.30

g/L

Analytical Range SI Units SI Units

Serum/Plasma 1.5-30 mg/dL 89-1785 μmol/L N/A N/A

Urine 1-100 mg/dL 60-5950 μmol/24

hrs

4-200mg/dL 0.04-2 g/L

CSF N/A N/A 4-200mg/dL 0.04-2 g/L

Precision Specification SI Units SI Units

Serum/Plasma < 3% CV < 3% CV N/A N/A

Urine < 5% CV < 5% CV < 5% CV < 5% CV

CSF N/A N/A < 5% CV < 5% CV

Reagent Volume

AU400/AU600/AU640 R1 = 60 μL, R2 = 25 μL R1 = 190 μL

AU480/AU680/AU2700/AU5400 R1 = 48 μL, R2 = 20 μL R1 = 152 μL



OSR6198 (4 x 500 tests)

OSR6298 (4 x 700 tests)

OSR6170 (4 x 100 tests)

OSR6270 (4 x 270 tests)


OSR6198 (4 x 625 tests)

OSR6298 (4 x 880 tests)

OSR6698 (4 x 2265 tests)†

OSR6170 (4 x 125 tests)

OSR6270 (4 x 330 tests)

Liquid or Lyophilized Liquid Liquid

On-Instrument Stability 30 days 90 days

Storage Temperature +2 to +8°C +2 to +8°C

Calibration Frequency 30 days 90 days

Reagent Blank Frequency 30 days 90 days

Compatible Anticoagulants Heparin N/A


Urine: DR0090

Urine: DR0090 only

Urine/CSF: Included in kit



No specific recommendation

Control Part Number N/A N/A

Comment(s) † AU2700/AU5400 only

15

Proteins/Serology

Chemistry Name Alpha-1-Acidglycoprotein Alpha-1-Antitrypsin Anti-Streptolysin O

Chemistry Abbreviation AAG AAT ASO

Measurement Principle Immunoturbidimetric Immunoturbidimetric Latex Particle Immunoturbidimetric

Reaction Type End End Fixed



Sample Type Serum Serum Serum



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 44-113 mg/dL 0.44-1.13 g/L 84-218 mg/dL 0.84-2.18 g/L 0-250 IU/mL 0-250 IU/mL




Serum/Plasma 20-200 mg/dL 0.2-2 g/L 30-500 mg/dL 0.3-5 g/L 100-1000 IU/mL 100-1000 IU/mL







Reagent Volume

AU400/AU600/AU640 R1 = 200 μL, R2 = 45 μL R1 = 200 μL, R2 = 65 μL R1 = 182 μL, R2 = 25 μL1

AU480/AU680/AU2700/AU5400 R1 = 160 μL, R2 = 36 μL R1 = 160 μL, R2 = 52 μL R1 = 182 μL, R2 = 25 μL1

Cartridge/Kit Size

AU400/AU640 OSR6162 (4 x 100 tests) OSR6163 (4 x 100 tests) OSR6194 (4 x 280 tests)

AU480/AU680/AU2700/AU5400 OSR6162 (4 x 120 tests) OSR6163 (4 x 120 tests) OSR6194 (4 x 280 tests)






Compatible Anticoagulants N/A N/A N/A

Calibrator Part Number ODR3023 ODR3023 ODR3021

Control Name Bio-Rad* Bio-Rad* Bio-Rad*


Comment(s) 1 Gently invert R2 5-10 times before

placing on instrument and weekly

16

Proteins/Serology

Chemistry Name Apolipoprotein A1 Apolipoprotein B Beta-2 Microglobulin

Chemistry Abbreviation APO A1 APO B B2M

Measurement Principle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric

Reaction Type End End Fixed



Sample Type Serum Serum Serum



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 1.6 μL 1.6 μL 1.6 μL

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 100-200 mg/dL 1-2 g/L 50-155 mg/dL 0.5-1.6 g/L 0.097-0.184 mg/dL 0.00097-0.00184

g/L




Serum/Plasma 40-250 mg/dL 0.4-2.5 g/L 40-200 mg/dL 0.4-2.0 g/L 0.05-1.6 mg/dL 0.0005-0.016 g/L







Reagent Volume



Cartridge/Kit Size

AU400/AU600/AU640 OSR6142 (4 x 200 tests) OSR6143 (4 x 200 tests) OSR6151 (4 x 100 tests)











Comment(s)

17

Proteins/Serology

Chemistry Name Ceruloplasmin Complement 3 Complement 4

Chemistry Abbreviation CER C3 C4





Sample Type Serum/Plasma Serum Serum



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 180-580 mg/L 18-58 mg/dL 87-200 mg/dL 0.87-2.0 g/L 19-52 mg/dL 0.19-0.52 g/L




Serum/Plasma 60-2000 mg/L 6-200 mg/dL 15-500 mg/dL 0.15-5.0 g/L 8-150 mg/dL 0.08-1.5 g/L







Reagent Volume



Cartridge/Kit Size








Compatible Anticoagulants Heparin N/A N/A




Comment(s)

18

Proteins/Serology

Chemistry Name C-Reactive Protein C-Reactive Protein C-Reactive Protein, High Sensitivity

Chemistry Abbreviation CRP CRPN CRPHS

Measurement Principle Immunoturbidimetric Latex Particle Immunoturbidimetric Latex Particle Immunoturbidimetric

Reaction Type Fixed Fixed Fixed



Sample Type Serum Serum/Plasma Serum/Plasma



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma AU480/680: 18 μL

AU2700/AU5400: 15 μL

1.6 μL AU480/680: 3.0 μL

AU2700/AU5400: 3.5 μL

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma < 5 mg/L < 0.5 mg/dL < 10 mg/L < 1 mg/dL < 10 mg/L < 1 mg/dL




Serum/Plasma 5-300 mg/L 0.5-30 mg/dL 1-480 mg/L 0.1-48 mg/dL 0.2-160 mg/L 0.02-16 mg/dL




Serum/Plasma < 5% CV or SD

≤ 1 mg/L1

< 5% CV or SD

≤ 0.1 mg/dL1

≤10% CV or SD

≤ 0.25 mg/L1

≤ 10% CV or SD

≤ 0.025 mg/dL1

< 10% CV or SD

≤ 0.02 mg/L1

≤ 10% CV or SD

≤ 0.002 mg/dL1



Reagent Volume


AU480/AU680/AU2700/AU5400 AU480/AU680: R1 = 70 μL, R2 = 30 μL

AU2700/AU5400: R1 = 47 μL, R2 = 20 μL

R1 = 120 μL, R2 = 120 μL2 R1 = 75 μL, R2 = 75 μL

Cartridge/Kit Size


AU480/AU680/AU2700/AU5400 OSR6147

AU480/AU680 (4 x 200 tests)

AU2700/AU5400 (4 x 300 tests)







Compatible Anticoagulants N/A EDTA

Lithium Heparin

EDTA

Lithium Heparin

Calibrator Part Number ODR3021 ODC0026 ODC0027



Comment(s) 1 Use the greater number 1 Use the greater number2 Gently invert R2 5-10 times before


1 Use the greater number

19

Proteins/Serology

Chemistry Name Ferritin Haptoglobin Immunoglobulin A

Chemistry Abbreviation FERR HAPT IGA

Measurement Principle Latex Particle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric

Reaction Type Fixed End End


Measuring Points 12, 18 0 , 27/0, 10 0, 27/0, 10

Sample Type Serum Serum Serum/Plasma



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 12-200 ng/mL 12-200 μg/L 44-215 mg/dL 0.44-2.15 g/L 66-433 mg/dL 0.66-4.33 g/L




Serum/Plasma 8-450 ng/mL 8-450 μg/L 30-400 mg/dL 0.3-4.0 g/L 10-700 mg/dL 0.1-7.0 g/L







Reagent Volume

AU400/AU600/AU640 R1 = 120 μL, R2 = 25 μL1 R1 = 165 μL, R2 = 45 μL R1 = 70 μL, R2 = 55 μL

AU480/AU680/AU2700/AU5400 R1 = 120 μL, R2 = 25 μL1 R1 = 182 μL, R2 = 25 μL R1 = 56 μL, R2 = 44 μL

Cartridge/Kit Size








Compatible Anticoagulants N/A N/A EDTA

Lithium Heparin






20

Proteins/Serology

Chemistry Name Immunoglobulin G Immunoglobulin M Microalbumin

Chemistry Abbreviation IGG IGM MALB



Primary Wavelength Serum/Plasma: 600 nm

CSF: 340 nm

340 nm 340 nm


Sample Type Serum/Plasma/CSF Serum/Plasma Urine


Serum/Plasma 2 μL 2 μL N/A

Urine N/A N/A 5 μL

CSF 10 μL N/A N/A


AU2700/AU5400)

Serum/Plasma 1.6 μL 1.6 μL N/A

Urine N/A N/A 4 μL

CSF 10 μL N/A N/A


Serum/Plasma 635-1741 mg/dL 6.35-17.41 g/L 45-281 mg/dL 0.45-2.81 g/L N/A N/A

Urine N/A N/A N/A N/A < 30 mg/24 hrs < 0.03 g/24 hrs

CSF 15–20 y:

3.5 mg/dL ± 2.0

mg/dL

21– 40 y:

4.2 mg/dL ± 1.4

mg/dL

41– 60 y:

4.7 mg/dL ± 1.0

mg/dL

15–20 y:

0.035 g/L ± 0.02

g/L

21– 40 y:

0.042 g/L ± 0.014

g/L

41– 60 y:

0.047 g/L ± 0.01

g/L

N/A N/A N/A N/A


Serum/Plasma 75-3000 mg/dL 0.75-30 g/L 20-500 mg/dL 0.2-5.0 g/L N/A N/A

Urine N/A N/A N/A N/A 0.5-30 mg/dL 0.005-0.30 g/L

CSF 2-50 mg/dL 0.02-0.50 g/L N/A N/A N/A N/A


Serum/Plasma < 7.5% CV or SD

< 0.5 mg/dL1

< 7.5% CV or SD

< 0.005 g/L1

< 10% CV < 10% CV N/A N/A

Urine N/A N/A N/A N/A < 10% CV < 10% CV

CSF < 6% < 6% N/A N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 Serum: R1 = 110 μL, R2 = 100 μL

CSF: R1 = 110 μL, R2 = 68 μL

R1 = 70 μL, R2 = 55 μL R1 = 150 μL, R2 = 50 μL

AU480/AU680/AU2700/AU5400 Serum: R1 = 87 μL, R2 = 80 μL

CSF: R1 = 110 μL, R2 = 68 μL

R1 = 56 μL, R2 = 44 μL R1 = 120 μL, R2 = 40 μL

Cartridge/Kit Size






Calibration Frequency Serum/Plasma: 90 days

CSF: 2 days

90 days 90 days

Reagent Blank Frequency Serum/Plasma: 90 days

CSF: 2 days

90 days 90 days


Lithium Heparin

EDTA

Lithium Heparin

N/A




Comment(s) 1 Use the greater number

21

Proteins/Serology

Chemistry Name Prealbumin Rheumatoid Factor Transferrin

Chemistry Abbreviation PALB RF TRF

Measurement Principle Immunoturbidimetric Latex Particle Immunoturbidimetric Immunoturbidimetric

Reaction Type End Fixed End


Measuring Points 0, 27/0, 10 12, 19 0, 27/0, 10

Sample Type Serum Serum/Plasma Serum



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 2.4 μL 2.6 μL 1.6 μL

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 17-34 mg/dL 0.17-0.34 g/L ≤ 14 IU/mL ≤ 14 IU/mL 203-362 mg/dL 2.0-3.6 g/L




Serum/Plasma 3-80 mg/dL 0.03-0.80 g/L 10-120 IU/L 10-120 IU/L 75-750 mg/dL 0.75-7.5 g/L







Reagent Volume


AU480/AU680/AU2700/AU5400 R1 = 120 μL, R2 = 52 μL R1 = 96 μL, R2 = 32 μL1 R1 = 28 μL, R2 = 32 μL

Kit Size








Compatible Anticoagulants N/A Lithium Heparin

EDTA

N/A

Calibrator Part Number ODR3029 ODC0028 ODR3021





22

Esoterics

Chemistry Name Ammonia Cholinesterase Creatine Kinase MB

Chemistry Abbreviation AMMON CHE CKMB

Measurement Principle Enzymatic Glutamate Dehydrogenase Butyrylthiocholine Immuno-inhibition UV/NADP

Reaction Type Fixed Rate Rate



Sample Type Plasma Serum/Plasma Serum/Plasma



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 25-90 μg/dL 16-53 μmol/L 4.9-11.9 kU/L 82-198 μkat/L 0-10 U/L 0-0.167 μkat/L




Serum/Plasma 17-1020 μg/dL 10-600 μmol/L 1-15 kU/L 17-250 μkat/L 10-2000 U/L 0.17-33.3 μkat/L




Serum/Plasma < 5% CV < 5% CV < 10% CV < 10% CV < 6.5% CV or SD

≤ 2 U/L1

< 6.5% CV or SD

≤ 0.03 μkat/L1



Reagent Volume

AU400/AU600/AU640 R1 = 150 R1 = 150 μL, R2 = 30 μL R1 = 120 μL, R2 = 30 μL2

AU480/AU680/AU2700/AU5400 R1 = 125 R1 = 150 μL, R2 = 30 μL R1 = 100 μL, R2 = 25 μL2







Calibration Frequency 7 days N/A N/A



Lithium Heparin

Heparin

EDTA

Heparin

Calibrator Part Number Included N/A N/A

Control Name Bio-Rad* Bio-Rad* No specific recommendation


Comment(s) 1 Use the greater number2 Transfer R1-2 into R1-1

23

Esoterics

Chemistry Name Hemoglobin A1c Lactate Lithium

Chemistry Abbreviation HBA1C LAC LI

Measurement Principle Turbidimetric Immuno-inhibition Enzymatic Colorimetric/Endpoint

Reaction Type Thb: End

HbA1c: Fixed

Fixed End

Primary Wavelength Thb: 600 nm

HbA1c: 700 nm

540 nm 520 nm

Measuring Points THb: 0, 27

HbA1c: 13, 22

1, 15 0, 6

Sample Type Pre-treated Whole Blood Plasma/CSF Serum/Plasma


Serum/Plasma N/A 2 μL 2 μL of a 1/10

Urine N/A N/A N/A

CSF N/A 2 μL N/A

Other THb: 11.0 μL1

HbA1c: 3.5 μL1

N/A N/A


AU2700/AU5400)

Serum/Plasma N/A 1.6 μL 2 μL of a 1/10

Urine N/A N/A N/A

CSF N/A 1.6 μL N/A

Other THb: 9.5 μL1

HbA1c: 3 μL1

N/A N/A


Serum/Plasma N/A N/A 4.5-19.8 mg/dL 0.5-2.2 mmol/L 1.0-1.2 mmol/L

(trough)

1.0-1.2 mEq/L

(trough)


CSF N/A N/A Neonate:

10-60 mg/dL

3-10 days old:

10-40 mg/dL

> 10 days old:

10-25 mg/dL

Adult: 10-22 mg/dL

Neonate:

1.1-6.7 mmol/L

3-10 days old:

1.1-4.4 mmol/L

> 10 days old:

1.1-2.8 mmol/L

Adult: 1.1-2.4

mmol/L

N/A N/A

Other HbA1c: 4.0-6.2% HbA1c: 4.0-

6.2%

N/A N/A N/A N/A


Serum/Plasma N/A N/A 2-90 mg/dL 0.2-10 mmol/L 0.1-5.0 mmol/L 0.1-5.0 mEq/L


CSF N/A N/A 2-90 mg/dL 0.2-10 mmol/L N/A N/A

Other 2.6% - highest

calibrator

2.6% - highest

calibrator

N/A N/A N/A N/A


Serum/Plasma ≤ 4% CV ≤ 4% CV < 5% CV < 5% CV < 5% CV < 5% CV



Reagent Volume

AU400/AU600/AU640 THb: R1 = 150

HbA1c: R1 = 76, R2 = 762

R1 = 200 R1 = 150

AU480/AU680/AU2700/AU5400 THb: R1 = 130

HbA1c: R1 = 65, R2 = 652

R1 = 160 R1 = 150


AU400/AU600/AU640 OSR6192 (2 x 250 tests) OSR6193 (4 x 50 tests) OSRT056 (2 x 113 tests

AU480/AU680/AU2700/AU5400 OSR6192 (2 x 250 tests) OSR6193 (4 x 60 tests) OSRT056 (2 x 113 tests)

Liquid or Lyophilized Liquid Lyophilized Liquid





Compatible Anticoagulants K2 EDTA

NH4 Heparinized Whole Blood

Sodium Fluoride

Potassium Oxalate

EDTA

Calibrator Part Number ODR3032 DR0070-2 Included

Control Name HbA1c Control Bio-Rad*/MAS Bio-Rad*/MAS

Control Part Number ODC0022 N/A N/A

Comment(s) 1 Whole blood values 2 Gently invert R2 5-10 times before


24

Thyroids

Chemistry Name Thyroxine T-Uptake

Chemistry Abbreviation T4 TUP

Measurement Principle Homogenous Enzymatic Immunoassay Homogenous Enzymatic Immunoassay

Reaction Type Fixed 1 Fixed 1

Primary Wavelength 340 nm 340 nm

Measuring Points 14, 20 14, 20

Sample Type Serum/Plasma Serum/Plasma


Serum/Plasma 4 μL 8 μL

Urine N/A N/A

CSF N/A N/A


AU2700/AU5400)

Serum/Plasma 4 μL 8 μL

Urine N/A N/A

CSF N/A N/A

Reference Interval SI Units SI Units

Serum/Plasma 4.5-12 μg/dL 58-154 nmol/L 23-36% 23-36%


CSF N/A N/A N/A N/A

Analytical Range SI Units SI Units

Serum/Plasma 0.7-20 μg/dL 9-257 nmol/L 15-50% 15-50%


CSF N/A N/A N/A N/A

Precision Specification SI Units SI Units

Serum/Plasma typical CV ≤ 4.3% typical CV

≤ 4.3%

typical CV ≤ 3.6% typical CV

≤ 3.6%


CSF N/A N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 180, R2 = 60 R1 = 180, R2 = 60

AU480/AU680/AU2700/AU5400 R1 = 180, R2 = 60 R1 = 180, R2 = 60


AU400/AU600/AU640 0454 (510 tests) 0723 (510 tests)

AU480/AU680/AU2700/AU5400 0454 (510 tests) 0723 (510 tests)

Liquid or Lyophilized Liquid Liquid

On-Instrument Stability 60 days 60 days

Storage Temperature +2 to +8°C +2 to +8°C

Calibration Frequency 14 days 14 days

Reagent Blank Frequency 14 days 14 days


Citrate

Oxalate

EDTA

Heparin

Citrate

Oxalate

EDTA

Calibrator Part Number 0476 0738

Control Name Bio-Rad*/MAS Bio-Rad*/MAS

Control Part Number N/A N/A

Comment(s) User-defined reagent User-defined reagent

25

Therapeutic Drug Monitoring (TDM)

Chemistry Name Acetaminophen Amikacin Caffeine

Chemistry Abbreviation ACETA AMIK CAFF

Measurement Principle Emit* tox Emit* TDM Emit* TDM

Reaction Type Rate Rate Rate



Sample Type Serum/Plasma Serum/Plasma Serum



Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 3 μL (AU480: 2.4 μL) 3 μL (AU480: 1.7 μL) 3 μL (AU480: 1.7 μL)

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma Consult literature Consult

literature

Consult literature Consult

literature


literature




Serum/Plasma 10-200 μg/mL 66-1324 μmol/L 2.5-50 μg/mL 4.3-85.5 μmol/L 1-30 μg/mL 5-155 μmol/L




Serum/Plasma typical CV ≤ 5% typical CV ≤ 5% typical CV ≤ 3.9% typical CV ≤ 3.9% typical CV ≤ 4.2% typical CV ≤ 4.2%



Reagent Volume

AU400/AU600/AU640 R1 = 150, R2 = 75 R1 = 162, R2 = 162 R1 = 162, R2 = 162

AU480/AU680/AU2700/AU5400 R1 = 150, R2 = 75

(AU480: R1 = 120, R2 = 60)

R1 = 162, R2 = 162

(AU480: R1 = 89, R2 = 89)

R1 = 162, R2 = 162

(AU480: R1 =89, R2 = 89)

Kit Part Number/Size

AU400/AU600/AU640 OSR7A229 (2 x 200 tests) 6X019 (275 tests) 6P419 (145 tests)

AU480/AU680/AU2700/AU5400 OSR7A229 (2 x 200 tests) 6X019 (275 tests) 6P419 (145 tests)

Liquid or Lyophilized Liquid Lyophilized Lyophilized






Heparin

Citrate

Oxalate/Fluoride

EDTA

Citrate

Oxalate

N/A

Calibrator Part Number 7A409 Included Included

Control Name Bio-Rad*/MAS Bio-Rad* Bio-Rad*



26


Chemistry Name Carbamazepine Digoxin Disopyramide

Chemistry Abbreviation CARB DIG DISO

Measurement Principle Emit* 2000 Emit* 2000 Emit* TDM







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 4-12 μg/mL 17-51 μmol/L 0.9-2.0 ng/mL 1.2-2.6 nmol/L 3-5 μg/mL 9-15 μmol/L




Serum/Plasma 2-20 μg/mL 8.5-84.6 μmol/L 0.2-5.0 ng/mL 0.3-6.4 nmol/L 0.5-8 μg/mL 1.5-23.6 μmol/L




Serum/Plasma typical CV ≤ 6.5% typical CV ≤ 6.5% typical CV ≤ 10.4% typical CV ≤ 10.4% typical CV ≤ 4.6% typical CV ≤ 4.6%



Reagent Volume

AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 130, R2 = 50 R1 = 162, R2 = 162

AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)

R1 = 130, R2 = 50

(AU480: R1 = 104, R2 = 40)

R1 = 162, R2 = 162

(AU480: R1 =89, R2 = 89)


AU400/AU600/AU640 OSR4F229 (2 x 200 tests) OSR4H229 (2 x 200 tests) 6N319 (275 tests)

AU480/AU680/AU2700/AU5400 OSR4F229 (2 x 200 tests) OSR4H229 (2 x 200 tests) 6N319 (275 tests)

Liquid or Lyophilized Liquid Liquid Lyophilized






Oxalate

Citrate

EDTA

Heparin

Oxalate

EDTA

Heparin

EDTA

Oxalate

Calibrator Part Number 4F109 4H209 Included



Comment(s) User-defined reagent

27


Chemistry Name Ethosuximide Gentamicin Lidocaine

Chemistry Abbreviation SUXI GENT LIDO

Measurement Principle Emit* TDM Emit* 2000 Emit* TDM







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 4.5 μL (AU480: 2.5 μL) 2 μL (AU480: 1.6 μL) 3 μL (AU480: 1.7 μL)

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 40-100 μg/mL 283-708 μmol/L Peak 4.0-8.0

μg/mL

Peak 8.6-17.0

μmol/L

1.5-5.0 μg/mL 6-21 μmol/L




Serum/Plasma 10-150 μg/mL 71-1062 μmol/L 0.25-10 μg/mL 0.5-20.9 μmol/L 1-12 μg/mL 4.3-51.2 μmol/L







Reagent Volume

AU400/AU600/AU640 R1 = 200, R2 = 200 R1 = 100, R2 = 50 R1 = 162, R2 = 162

AU480/AU680/AU2700/AU5400 R1 = 200, R2 = 200

(AU480: R1 = 110, R2 = 110)

R1 = 100, R2 = 50

(AU480: R1 = 80, R2= 40)

R1 = 162, R2 = 162

(AU480: R1 = 89, R2 = 89)


AU400/AU600/AU640 6E119 (120 tests) OSR4T229 (2 x 200 tests) 6M119 (145 tests)

AU480/AU680/AU2700/AU5400 6E119 (120 tests) OSR4T229 (2 x 200 tests) 6M119 (145 tests)

Liquid or Lyophilized Lyophilized Liquid Lyophilized

On-Instrument Stability 56 days and as required 90 days 28 days





EDTA

Heparin

Citrate

Oxalate

EDTA

Heparin

EDTA

Oxalate

Calibrator Part Number 6A089 4T209 Included

Control Name Bio-Rad* Bio-Rad*/MAS Bio-Rad*



28


Chemistry Name Methotrexate N-Acetylprocainamide Phenobarbital

Chemistry Abbreviation MTRX NAPA PBARB

Measurement Principle Emit* TDM Emit* 2000 Emit* 2000







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 3.0 μL (AU480: 1.7 μL) 2 μL (AU480: 1.6 μL) 2 μL (AU480: 1.6 μL)

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma Consult literature Consult

literature


literature

10-40 μg/mL 43-172 μmol/L




Serum/Plasma 0.3-2600 μmol/L 3 x 10-7 – 2.6 x

10-3 mol/L)

1-16 μg/mL 3.6-57.8 μmol/L 5-80 μg/mL 22-345 μmol/L







Reagent Volume

AU400/AU600/AU640 R1 = 162, R2 = 162 R1 = 100, R2 = 50 R1 = 90, R2 = 90

AU480/AU680/AU2700/AU5400 R1 = 162, R2 = 162

(AU480: R1 = 89, R2 = 89)

R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)

R1= 90, R2 = 90

(AU480: R1 = 72, R2 = 72)


AU400/AU600/AU640 6L119 (130 tests) OSR4N229 (2 x 200 tests) OSR4D229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 6L119 (130 tests) OSR4N229 (2 x 200 tests) OSR4D229 (2 x 200 tests)

Liquid or Lyophilized Lyophilized Liquid Liquid






EDTA

Oxalate

Heparin

Citrate

Oxalate

EDTA

Heparin

Citrate

Oxalate

EDTA

Calibrator Part Number Included 4N109 4D109




29


Chemistry Name Phenytoin Primidone Procainamide

Chemistry Abbreviation PHENY PRIM PROC

Measurement Principle Emit* 2000 Emit* TDM Emit* 2000







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)


Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 10-20 μg/mL 40-79 μmol/L 5-12 μg/mL 23-55 μmol/L 4-10 μg/mL 17-43 μmol/L




Serum/Plasma 2.5-40 μg/mL 10-158 μmol/L 2.5-20 μg/mL 11-92 μmol/L 1-12 μg/mL 4.3-51 μmol/L







Reagent Volume

AU400/AU600/AU640 R1 = 90, R2 = 65 R1 = 100, R2 = 100 R1 = 100, R2 = 50

AU480/AU680/ AU2700/AU5400 R1 = 90, R2 = 65

(AU480: R1 = 72, R2 = 52)

R1 = 100, R2 = 100

(AU480: R1 = 60, R2 = 60)

R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)


AU400/AU600/AU640 OSR4A229 (2 x 200 tests) 6C119 (240 tests) OSR4K229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR4A229 (2 x 200 tests) 6C119 (240 tests) OSR4K229 (2 x 200 tests)


On-Instrument Stability 90 days 84 days and as required 90 days





Citrate

Oxalate

EDTA

Heparin

EDTA

Heparin

Citrate

Oxalate

EDTA

Calibrator Part Number 4A109 6A089 4K109




30


Chemistry Name Quinidine Salicylic Acid Theophylline

Chemistry Abbreviation QUIN SALI THEO

Measurement Principle Emit* 2000 Emit* tox Emit* 2000







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 2 μL (AU480: 1.6 μL) 3 μL ( AU480: 2.4 μL) 3 μL (AU480: 2.4 μL)

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma 2 – 5 μg/mL 6.2-15 μmol/L < 6 mg/dL < 434 μmol/L 10-20 μg/mL 56-111 μmol/L




Serum/Plasma 0.5-8 μg/mL 1.5-25 μmol/L 2.5-80 mg/dL 181-5792 μmol/L 2.5-40 μg/mL 14-222 μmol/L




Serum/Plasma typical CV ≤ 9.3% typical CV ≤ 9.3% < 8.5% CV < 8.5% CV typical CV ≤ 11.3% typical CV ≤ 11.3%



Reagent Volume

AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 150, R2 = 75 R1 = 100, R2 = 50

AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)

R1 = 150, R2 = 75

(AU480: R1 = 120, R2 = 60)

R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)


AU400/AU600/AU640 OSR4Q229 (2 x 200 tests) OSR7S229 (2 x 200 tests) OSR4P229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR4Q229 (2 x 200 tests) OSR7S229 (2 x 200 tests) OSR4P229 (2 x 200 tests)







Citrate

Oxalate

EDTA

EDTA

Sodium Heparin

Citrate

Oxalate/Fluoride

Heparin

Citrate

Oxalate

EDTA

Calibrator Part Number 4Q109 7S109 4P109



Comment(s)

31


Chemistry Name Tobramycin Valproic Acid Vancomycin

Chemistry Abbreviation TOB VPA VANC

Measurement Principle Emit* 2000 Emit* 2000 Emit* 2000







Urine N/A N/A N/A

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 3.5 μL (AU480: 2.8 μL) 3.5 μL (AU480: 2.8 μL) 3 μL (AU480: 2.4 μL)

Urine N/A N/A N/A

CSF N/A N/A N/A


Serum/Plasma Peak 4-8 μg/mL Peak 8.6-17.1

μmol/L

50-100 μg/mL 347-693 μmol/L Consult literature Consult

literature




Serum/Plasma 0.6-10 μg/mL 1.3-21.4 μmol/L 10-150 μg/mL 69-1040 μmol/L 2-50 μg/mL 1.3-34 μmol/L




Serum/Plasma typical CV ≤ 6.8% typical CV ≤ 6.8% typical CV ≤ 4.3% typical CV

≤ 4.3%

typical CV ≤ 3.8% typical CV

≤ 3.8%



Reagent Volume

AU400/AU600/AU640 R1 = 174, R2 = 87 R1 = 174, R2 = 87 R1 = 150, R2 = 80

AU480/AU680/AU2700/AU5400 R1 = 174, R2 = 87

(AU480: R1 = 139, R2 = 70)

R1 = 174, R2 = 87

(AU480: R1 = 139, R2 = 70)

R1 = 150, R2 = 80

(AU480: R1 = 120, R2 = 64)


AU400/AU600/AU640 OSR4S229 (2 x 200 tests) OSR4G229 (2 x 200 tests) OSR4W229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR4S229 (2 x 200 tests) OSR4G229 (2 x 200 tests) OSR4W229 (2 x 200 tests)






Compatible Anticoagulants Sodium Heparin

Citrate

Oxalate/Fluoride

EDTA

EDTA

Heparin

Citrate

Oxalate/Fluoride

EDTA

Sodium Heparin

Lithium Heparin

Citrate

Oxalate/Fluoride

Calibrator Part Number 4S109 4G109 4W109



Comment(s)

32

Drugs of Abuse Testing (DAT)

Chemistry NameAmphetamines

(300 cutoff)

Amphetamines

(500 cutoff)

Amphetamines

(1000 cutoff)

Chemistry Abbreviation AMPH+ AMPH+ AMPH+

Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus




Sample Type Urine Urine Urine


Serum/Plasma N/A N/A N/A

Urine 5.0 μL 3.0 μL 2.0 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine 5.0 μL (AU480: 3.5 μL) 3.0 μL (AU480: 2.1 μL) 2.0 μL (AU480: 1.6 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 300 ng/mL 500 ng/mL 1000 ng/mL

CSF N/A N/A N/A

Analytical Range (UDR)


Urine User defined User defined User defined

CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 150, R2 = 65 R1 = 150, R2 = 65 R1 = 158, R2 = 68

AU480/AU680/AU2700/AU5400

R1 = 150, R2 = 65

(AU480: R1 = 105, R2 = 46)

R1 = 150, R2 = 65

(AU480: R1 = 105, R2 = 46)

R1 = 158, R2 = 68

(AU480: R1 = 126, R2 = 54)


AU400/AU600/AU640 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)







Calibrator Part Number 9A529 9A549 9A569

Control Name No specific recommendation No specific recommendation No specific recommendation


Comment(s)

33


Chemistry NameAmphetamines

(300 cutoff/semi-quantitative)

Amphetamines


Amphetamines


Chemistry Abbreviation AMPH+ AMPH+ AMPH+









CSF N/A N/A N/A


AU2700/AU5400)



CSF N/A N/A N/A

Cutoff Level



CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 150, R2 = 65 R1 = 150, R2 = 65 R1 = 158, R2 = 68

AU480/AU680/AU2700/AU5400

R1 = 150, R2 = 65

(AU480: R1 = 105, R2 = 46)

R1 = 150, R2 = 65

(AU480: R1 = 105, R2 = 46)

R1 = 158, R2 = 68

(AU480: R1 = 126, R2 = 54)


AU400/AU600/AU640 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)







Calibrator Part Number 9A529, 9A549, 9A569 9A529, 9A549, 9A569 9A529, 9A549, 9A569, 9A609



Comment(s)

34


Chemistry NameBarbiturate

(200 cutoff)

Barbiturate

(300 cutoff)

Barbiturate

(semi-quantitative)

Chemistry Abbreviation BARB+ BARB+ BARB+









CSF N/A N/A N/A


AU2700/AU5400)



CSF N/A N/A N/A

Cutoff Level


Urine 200 ng/mL 300 ng/mL 200/300 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 140, R2 = 60 R1 = 140, R2 = 60

AU480/AU680/AU2700/AU5400

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1= 140, R2 = 60

(AU480: R1 = 98, R2 = 42)


AU400/AU600/AU640 OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests)







Calibrator Part Number 9A569 9A589 9A549, 9A569, 9A589, 9A609



Comment(s)

35


Chemistry Name Barbiturate, ToxBenzodiazepine

(200 cutoff)

Benzodiazepine

(300 cutoff)

Chemistry Abbreviation TBARB BENZ+ BENZ+

Measurement Principle Emit* tox Emit ll* Plus Emit ll* Plus




Sample Type Serum/Plasma Urine Urine


Serum/Plasma 3 μL N/A N/A

Urine N/A 6 μL 6 μL

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma 3 μL (AU480: 2.4 μL) N/A N/A

Urine N/A 6 μL (AU480: 4.2 μL) 6 μL (AU480: 4.2 μL)

CSF N/A N/A N/A

Cutoff Level


Urine N/A 200 ng/mL 300 ng/mL

CSF N/A N/A N/A


Serum/Plasma User defined N/A N/A

Urine N/A User defined User defined

CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 100, R2 = 100 R1 = 140, R2 = 60 R1 = 140, R2 = 60

AU480/AU680/AU2700/AU5400

R1 = 100, R2 = 100

(AU480: R1 = 80, R2 = 80)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)


AU400/AU600/AU640 7D119 (235 tests) OSR9F229 (2 x 200 tests) OSR9F229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 7D119 (235 tests) OSR9F229 (2 x 200 tests) OSR9F229 (2 x 200 tests)

Liquid or Lyophilized Lyophilized Liquid Liquid



Calibration Frequency 1 day 14 days 14 days

Reagent Blank Frequency 1 day 14 days 14 days


Oxalate

EDTA

N/A N/A

Calibrator Part Number 7B019 9A569 9A589




36


Chemistry NameBenzodiazepine

(semi-quantitative)Benzodiazepine, Tox

Cannabinoid

(20 cutoff)

Chemistry Abbreviation BENZ+ TBENZ THC20+





Sample Type Urine Serum/Plasma Urine


Serum/Plasma N/A 2.5 μL N/A

Urine 6 μL N/A 10 μL

CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma N/A 2.5 μL (AU480: 2 μL) N/A

Urine 6 μL (AU480: 4.2 μL) N/A 10 μL (AU480: 7 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 200/300 ng/mL N/A 20 ng/mL

CSF N/A N/A N/A


Serum/Plasma N/A User defined N/A

Urine User defined N/A User defined

CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 75, R2 = 75 R1 = 140, R2 = 60

AU480/AU680/AU2700/AU5400

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 75, R2 = 75

(AU480: R1 = 60, R2 = 60)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)


AU400/AU600/AU640 OSR9F229 (2 x 200 tests) 7B119 (300 tests) OSR9N229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9F229 (2 x 200 tests) 7B119 (300 tests) OSR9N229 (2 x 200 tests)




Calibration Frequency 14 days 1 day 14 days


Compatible Anticoagulants N/A Oxalate

EDTA

Heparin

N/A

Calibrator Part Number 9A549, 9A569, 9A589, 9A609 7B019 9A549




37


Chemistry NameCannabinoid

(50 cutoff)

Cannabinoid

(100 cutoff)

Cannabinoid

(semi-quantitative)

Chemistry Abbreviation THC50+ THC100+ THC50+









CSF N/A N/A N/A


AU2700/AU5400)



CSF N/A N/A N/A

Cutoff Level


Urine 50 ng/mL 100 ng/mL 20/50/100 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 160, R2 = 40 R1 = 140, R2 = 60

AU480/AU680/AU2700/AU5400

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 160, R2 = 40

(AU480: R1 = 112, R2 = 28)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)


AU400/AU600/AU640 OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests)







Calibrator Part Number 9A569 9A589 9A569, 9A589, 9A609



Comment(s)

38


Chemistry NameCocaine Metabolite

(150 cutoff)

Cocaine Metabolite

(300 cutoff)

Cocaine Metabolite

(semi-quantitative)

Chemistry Abbreviation COCA+ COCA+ COCA+









CSF N/A N/A N/A


AU2700/AU5400)


Urine 9 μL (AU480: 6.3 μL) 9 μL (AU480: 6.3 μL) 9 μL (AU480: 6.3 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 150 ng/mL 300 ng/mL 150/300 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 130, R2 = 55 R1 = 130, R2 = 55

AU480/AU680/AU2700/AU5400

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)


AU400/AU600/AU640 OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests)







Calibrator Part Number 9A549 9A569 9A549, 9A569, 9A589, 9A609



Comment(s)

39


Chemistry Name Creatinine, ToxEcstasy

(300 cutoff)

Ecstasy

(500 cutoff)

Chemistry Abbreviation CRTOX XTC XTC

Measurement Principle Modified Jaffe, Kinetic Emit ll* Plus Emit ll* Plus








CSF N/A N/A N/A


AU2700/AU5400)


Urine 3 μL 7 μL (AU480: 4.9 μL) 5 μL (AU480: 3.5 μL)

CSF N/A N/A N/A

Cutoff Level


Urine N/A 300 ng/mL 500 ng/mL

CSF N/A N/A N/A



Urine 1-100 mg/dL User defined User defined

CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 50, R2 = 50 R1 = 130, R2 = 55 R1 = 130, R2 = 55

AU480/AU680/AU2700/AU5400

R1 = 50, R2 = 50 R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)


AU400/AU600/AU640 OSR66100 (4 x 3070 tests)1 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR66100 (4 x 3070 tests)1 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests)







Calibrator Part Number Syva* cR Perfect* Calibrators: (3T129,

3T249, 3T139, 3T149)

9A509, 9X549, 9X589 9A509, 9X569, 9X589



Comment(s) 1 Available as user-defined reagent for

AU400/AU600/AU640/AU480/AU680

40


Chemistry NameEcstasy


Ecstasy

(500 cutoff/semi-quantitative)Ethyl Alcohol

Chemistry Abbreviation XTC XTC ETOH+





Sample Type Urine Urine Serum/Plasma/Urine


Serum/Plasma N/A N/A 4 μL


CSF N/A N/A N/A


AU2700/AU5400)

Serum/Plasma N/A N/A 4 μL (AU480: 2.8 μL)


CSF N/A N/A N/A

Cutoff Level


Urine 300 ng/mL 500 ng/mL N/A

CSF N/A N/A N/A


Serum/Plasma N/A N/A 10-600 mg/dL

Urine User defined User defined 10-600 mg/dL

CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 130, R2 = 55 R1 = 210, R2 = 90

AU480/AU680/AU2700/AU5400

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 210, R2 = 90

(AU480: R1 = 147, R2 = 63)


AU400/AU600/AU640 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests) OSR9K229 (2 x 130 tests)

AU480/AU680/AU2700/AU5400 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests) OSR9K229 (2 x 130 tests)


On-Instrument Stability 28 28 60 days




Compatible Anticoagulants N/A N/A Heparin

Oxalate/Fluoride

EDTA

Citrate

Calibrator Part Number 9A509, 9X529, 9X549, 9X569 9A529, 9X549, 9X569, 9X589 9K029, 9K059

Control Name No specific recommendation No specific recommendation Ethyl Alcohol Low Control

Ethyl Alcohol High Control

Control Part Number N/A N/A 9K049

9K079

Comment(s)

41


Chemistry NameLSD

(0.5 cutoff)

LSD

(semi-quantitative)

Methadone

(150 cutoff)

Chemistry Abbreviation LSD LSD2 METH+

Measurement Principle Emit II* Emit II* Emit ll* Plus








CSF N/A N/A N/A


AU2700/AU5400)


Urine 20 μL (AU480: 16 μL) 20 μL (AU480: 16 μL) 6 μL (AU480: 4.2 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 0.5 ng/mL 0.5 ng/mL 150 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 100, R2 = 50 R1 = 140, R2 = 60

AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)

R = 100, R2 = 50

(AU480: R1 = 80, R2 = 40)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)


AU400/AU600/AU640 9L019 (460 tests) 9L019 (460 tests) OSR9E229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 9L019 (460 tests) 9L019 (460 tests) OSR9E229 (2 x 200 tests)




Calibration Frequency 1 day 1 day 14 days

Reagent Blank Frequency 1 day 1 day 14 days


Calibrator Part Number 9L009, 9L209, 9L309 9L009, 9L109, 9L209, 9L309 9A549

Control Name LSD Level I Control

LSD Level II Control

LSD Level I Control

LSD Level II Control


Control Part Number 9L419

9L519

9L419

9L519

N/A


42


Chemistry NameMethadone

(300 cutoff)

Methadone

(semi-quantitative)

Methaqualone

(300 cutoff)

Chemistry Abbreviation METH+ METH+ METQ+








Urine 6 μL 6 μL 5.5 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine 6 μL (AU480: 4.2 μL) 6 μL (AU480: 4.2 μL) 5.5 μL (AU480: 3.9 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 300 ng/mL 150/300 ng/mL 300 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 140, R2 = 60 R1 = 130, R2 = 55

AU480/AU680/AU2700/AU5400

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 140, R2 = 60

(AU480: R1 = 98, R2 = 42)

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)


AU400/AU600/AU640 OSR9E229 (2 x 200 tests) OSR9E229 (2 x 200 tests) OSR9Q229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9E229 (2 x 200 tests) OSR9E229 (2 x 200 tests) OSR9Q229 (2 x 200 tests)







Calibrator Part Number 9A569 9A549, 9A569, 9A589, 9A609 9A569



Comment(s)

43


Chemistry NameMethaqualone

(semi-quantitative)

Opiates

(300 cutoff)

Opiates

(2000 cutoff)

Chemistry Abbreviation METQ+ OPIA+ OPIA+








Urine 5.5 μL 8 μL 3 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine 5.5 μL (AU480: 3.9 μL) 8 μL (AU480: 5.6 μL) 3 μL (AU480: 2.1 μL)

CSF N/A N/A N/A

Cutoff Level



CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 134, R2 = 50 R1 = 200, R2 = 75

AU480/AU680/AU2700/AU5400

R1 = 130, R2 = 55

(AU480: R1 = 91, R2 = 39)

R1 = 134, R2 = 50

(AU480: R1 = 94, R2 = 35)

R1 = 200, R2 = 75

(AU480: R1 = 140, R2 = 53)


AU400/AU600/AU640 OSR9Q229 (2 x 200 tests) OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9Q229 (2 x 200 tests) OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests)







Calibrator Part Number 9A549, 9A569, 9A589, 9A609 9A529 9A569



Comment(s)

44


Chemistry NameOpiates


Opiates


Oxycodone

(100 cutoff)

Chemistry Abbreviation OPIA+ OPIA+ OXY

Measurement Principle Emit ll* Plus Emit ll* Plus Homogeneous enzyme immunoassay

Reaction Type Fixed Fixed Rate







CSF N/A N/A N/A


AU2700/AU5400)


Urine 8 μL (AU480: 5.6 μL) 3 μL (AU480: 2.1 μL) 14 μL

CSF N/A N/A N/A

Cutoff Level



CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 134, R2 = 50 R1 = 200, R2 = 75 R1 = 87, R2 = 87

AU480/AU680/AU2700/AU5400

R1 = 134, R2 = 50

(AU480: R1 = 94, R2 = 35)

R1 = 200, R2 = 75

(AU480: R1 = 140, R2 = 53)

R1 = 87, R2 = 87


AU400/AU600/AU640 OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests) 100248-(DRI) 70 mL kit (650 tests/kit)

100249-(DRI) 500 mL kit (5400 tests/kit)

AU480/AU680/AU2700/AU5400 OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests) 100248-(DRI) 70 mL kit (650 tests/kit)








Calibrator Part Number 9A509, 9A529, 9A549, 9A569 9A509, 9A549, 9A569, 9A609 DRI* Calibrator: 100250

Control Name No specific recommendation No specific recommendation DRI* Oxycodone Control Kit 100

Control Part Number N/A N/A 100254


45


Chemistry NameOxycodone

(300 cutoff)

Oxycodone

(semi-quantitative)

Phencyclidine

(25 cutoff)

Chemistry Abbreviation OXY OXY PCP+

Measurement Principle Homogeneous enzyme immunoassay Homogeneous enzyme immunoassay Emit ll* Plus

Reaction Type Rate Rate Fixed






Urine 10.5 μL 10.5 μL 7 μL

CSF N/A N/A N/A


AU2700/AU5400)


Urine 10.5 μL 10.5 μL 7 μL (AU480: 4.9 μL)

CSF N/A N/A N/A

Cutoff Level


Urine 300 ng/mL 100/300 ng/mL 25 ng/mL

CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 87, R2 = 87 R1 = 87, R2 = 87 R1 = 120, R2 = 50

AU480/AU680/AU2700/AU5400

R 1= 87, R2 = 87 R1 = 87, R2 = 87 R1 = 120, R2 = 50

(AU480: R1 = 84, R2 = 35)


AU400/AU600/AU640 100248-(DRI) 70 mL kit (650 tests/kit)




OSR9J229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 100248-(DRI) 70 mL ki (650 tests/kit)t




OSR9J229 (2 x 200 tests)







Calibrator Part Number DRI* Calibrator: 100251 DRI* Calibrators:100250, 100251,

100252, 100253, 1664/1388 –Neg. cal

9A569

Control Name DRI* Oxycodone Control Kit 300 DRI* Oxycodone Control Kit 100

DRI* Oxycodone Control Kit 300


Control Part Number 100255 DRI* Oxycodone Control Kit 100:

100254

DRI* Oxycodone Control Kit 300:

100255

N/A


The negative calibrator 1664 has a

10 mL volume and the 1388 has a

25 mL volume

46


Chemistry NamePhencyclidine

(semi-quantitative)

Propoxyphene

(300 cutoff)

Propoxyphene

(semi-quantitative)

Chemistry Abbreviation PCP+ PPX+ PPX+









CSF N/A N/A N/A


AU2700/AU5400)



CSF N/A N/A N/A

Cutoff Level



CSF N/A N/A N/A




CSF N/A N/A N/A

Reagent Volume

AU400/AU600/AU640 R1 = 120, R2 = 50 R1 = 120, R2 = 50 R1= 120, R2 = 50

AU480/AU680/AU2700/AU5400

R1 = 120, R2 = 50

(AU480: R1 = 84, R2 = 35)

R1 = 120, R2 = 50

(AU480: R1 = 84, R2 = 35)

R1 = 120, R2 = 50

(AU480: R1 = 84, R2 = 35)


AU400/AU600/AU640 OSR9J229 (2 x 200 tests) OSR9G229 (2 x 200 tests) OSR9G229 (2 x 200 tests)

AU480/AU680/AU2700/AU5400 OSR9J229 (2 x 200 tests) OSR9G229 (2 x 200 tests) OSR9G229 (2 x 200 tests)







Calibrator Part Number 9A549, 9A569, 9A589, 9A609 9A569 9A549, 9A569, 9A589



Comment(s)

47


Chemistry Name Tricyclics, Tox

Chemistry Abbreviation TRICY

Measurement Principle Emit* tox

Reaction Type Fixed

Primary Wavelength 340 nm

Measuring Points 12, 16

(AU480: 13, 15)

Sample Type Serum/Plasma


Serum/Plasma 2.5 μL

Urine N/A

CSF N/A


AU2700/AU5400)

Serum/Plasma 2.5 μL (AU480: 2 μL)

Urine N/A

CSF N/A

Cutoff Level

Serum/Plasma N/A

Urine N/A

CSF N/A


Serum/Plasma User defined

Urine N/A

CSF N/A

Reagent Volume

AU400/AU600/AU640 R1 = 75, R2 = 75

AU480/AU680/AU2700/AU5400 R1 = 75, R2 = 75

(AU480: R1 = 60, R2 = 60)


AU400/AU600/AU640 7C209 (300 tests)

AU480/AU680/AU2700/AU5400 7C209 (300 tests)

Liquid or Lyophilized Lyophilized

On-Instrument Stability 35 days

Storage Temperature +2 to +8°C

Calibration Frequency 1 day

Reagent Blank Frequency 1 day


Oxalate

EDTA

Calibrator Part Number 7C219

Control Name No specific recommendation

Control Part Number N/A


49

Index

Acetaminophen (ACETA) ................................................................... 25

Alanine Aminotransferase (ALT) ..........................................................4

Albumin (ALB) .........................................................................................4

Alkaline Phosphatase (ALP) .................................................................4

Alpha-1-Acidglycoprotein (AAG) ...................................................... 15

Alpha-1-Antitrypsin (AAT) .................................................................. 15

Amylase (AMY)........................................................................................5

Amikacin (AMIK) .................................................................................. 25

Ammonia (AMMON) ........................................................................... 22

Amphetamines 300ng (AMPH+) ...................................................... 32

Amphetamines 500ng (AMPH+) ...................................................... 32

Amphetamines 1000ng (AMPH+) .................................................... 32

Amphetamines 300ng SQ (AMPH+) ............................................... 33

Amphetamines 500ng SQ (AMPH+) ............................................... 33

Amphetamines 1000ng SQ (AMPH+) ............................................. 33

Anti-Streptolysin O (ASO) ................................................................. 15

Apolipoprotein A1 (APO A1) ............................................................. 16

Apolipoprotein B (APO B) ................................................................. 16

Aspartate Aminotransferase (AST) ......................................................5

Barbiturate 200ng (BARB+) .............................................................. 34

Barbiturate 300ng (BARB+) .............................................................. 34

Barbiturate SQ (BARB+) ................................................................... 34

Barbiturate, Tox (TBARB) ................................................................... 35

Benzodiazepine 200ng (BENZ+) ..................................................... 35

Benzodiazepine 300ng (BENZ+) ..................................................... 35

Benzodiazepine SQ (BENZ+) .......................................................... 36

Benzodiazepine, Tox (TBENZ) .......................................................... 36

Beta-2 Microglobulin (B2M) ............................................................. 16

Bicarbonate (CO2) ................................................................................5

C-Reactive Protein (CRP) ................................................................. 18

C-Reactive Protein (CRPN) ............................................................. 18

C-Reactive Protein, High Sensitivity (CRPHS) .............................. 18

Caffeine (CAFF) .................................................................................. 26

Calcium Arsenazo (CALA) ....................................................................6

Calcium oCPC (CA) ..............................................................................6

Cannabinoid 20ng (THC) .................................................................. 36

Cannabinoid 50ng (THC) .................................................................. 37

Cannabinoid 100ng (THC) ................................................................ 37

Cannabinoid SQ (THC) ..................................................................... 37

Carbamazepine (CARB) .................................................................... 26

Ceruloplasmin (CER) ......................................................................... 17

Chloride (CL) ..........................................................................................6

Cholesterol (CHOL) ..............................................................................7

Cholinesterase (CHE) ........................................................................ 22

Cocaine Metabolite 150ng (COCA+) .............................................. 38

Cocaine Metabolite 300ng (COCA+) .............................................. 38

Cocaine Metabolite SQ (COCA+) ................................................... 38

Complement 3 (C3) ............................................................................ 17

Complement 4 (C4) ............................................................................ 17

Creatine Kinase MB (CKMB) ............................................................ 22

Creatinine (CRE) ....................................................................................7

Creatine Kinase (CK) .............................................................................7

Creatinine, Tox (CRTOX) .................................................................... 40

Digoxin (DIG) ....................................................................................... 27

Direct Bilirubin (DBIL) ...........................................................................8

Disopyramide (DISO) ......................................................................... 27

Ecstasy 300ng (XTC) ......................................................................... 39

Ecstasy 500ng (XTC) ......................................................................... 39

Ecstasy 300ng SQ (XTC) .................................................................. 40

Ecstasy 500ng SQ (XTC) .................................................................. 40

Ethosuximide (SUXI) ........................................................................... 27

Ethyl Alcohol (ETOH+) ....................................................................... 40

Ferritin (FERR) ..................................................................................... 19

Gamma-Glutamyltransferase (GGT) ...................................................8

Gentamicin (GENT) ............................................................................ 27

Glucose (GLU) .......................................................................................9

Haptoglobin (HAPT) ........................................................................... 19

HDL Cholesterol (HDL-C) ....................................................................9

Hemoglobin A1c (IFCC) (HBA1C) .................................................. 23

Immunoglobulin A (IGA) ..................................................................... 19

Immunoglobulin G (IGG) ................................................................... 20

Immunoglobulin M (IGM) ................................................................... 20

Iron (IRON) ..............................................................................................9

Lactate (LAC) ....................................................................................... 23

Lactate Dehydrogenase (IFCC) (LDH) ............................................ 10

LDL Cholesterol (LDL-C) .................................................................. 10

Lidocaine (LIDO) ................................................................................. 27

Lipase (LIP) .......................................................................................... 10

Lithium (LI) ............................................................................................ 23

LSD (LSD) ............................................................................................ 41

LSD SQ (LSD) ..................................................................................... 41

Magnesium (MG) ................................................................................ 11

Methadone 150ng (METH+) ............................................................. 41

Methadone 300ng (METH+) ............................................................. 42

Methadone SQ (METH+) ................................................................... 42

Methaqualone (METQ+) .................................................................... 42

Methaqualone SQ (METQ+) ............................................................. 43

Methotrexate (MTRX) .......................................................................... 28

Microalbumin (MALB)......................................................................... 20

N-Acetylprocainamide (NAPA) .......................................................... 28

Opiates 300ng (OPIA+) ..................................................................... 43

Opiates 2000ng (OPIA+) .................................................................. 43

Opiates 300ng SQ (OPIA+).............................................................. 44

Opiates 2000ng SQ (OPIA+) ........................................................... 44

Oxycodone 100ng (OXY) ................................................................... 44

Oxycodone 300ng (OXY) .................................................................. 45

Oxycodone SQ (OXY) ........................................................................ 45

Phencyclidine (PCP+) ........................................................................ 45

Phencyclidine SQ (PCP+) ................................................................. 46

Phenobarbital (PBARB) ..................................................................... 28

Phenytoin (PHENY) ............................................................................ 29

Phosphorus, Inorganic (PHOS) ....................................................... 11

Potassium (K) ....................................................................................... 11

Prealbumin (PALB).............................................................................. 21

Primidone (PRIM) ................................................................................ 29

Procainamide (PROC) ....................................................................... 29

Propoxyphene (PPX+) ........................................................................ 46

Propoxyphene SQ (PPX+) ................................................................. 46

Quinidine (QUIN) ................................................................................ 30

Rheumatoid Factor (RF) ..................................................................... 21

Salicylic Acid (SALI) ........................................................................... 30

Sodium (NA)......................................................................................... 12

T-Uptake (TUP) .................................................................................... 24

Theophylline (THEO) .......................................................................... 30

Thyroxine (T4) ...................................................................................... 24

Tobramycin (TOB) ............................................................................... 31

Total Bilirubin (TBIL) ........................................................................... 12

Total Protein (TP) ................................................................................. 12

Transferrin (TRF) ................................................................................. 21

Triglyceride (TRIG) .............................................................................. 13

Tricyclics, Tox (TRICY)........................................................................ 45

Unsaturated Iron Binding Capacity (UIBC) .................................... 13

Urea Nitrogen (BUN) .......................................................................... 13

Uric Acid (UA) ...................................................................................... 14

Urinary/CSF Protein (UCSFP) .......................................................... 14

Valproic Acid (VPA) ............................................................................. 31

Vancomycin (VANC) ............................................................................ 31

Notes

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

____________________________________________________________________________________________________________________________

*All trademarks are the property of their respective owners.

Beckman Coulter, the stylized logo, AU, AU400, AU480, AU600, AU640, AU680, AU2700, AU5400 are

registered trademarks of Beckman Coulter, Inc.

Laboratories around the world rely on Beckman Coulter’s promise of

quality, integrity and innovation. Our total laboratory solutions deliver

accurate information for medical research breakthroughs, clinical trials,

laboratory diagnostics and point-of-care testing. A partnership with

Beckman Coulter extends far beyond our products. With extensive

expertise in analyzing laboratory test processes, we collaborate with

you to understand your requirements and create flexible solutions that

meet your evolving needs.

We’re better together. And together, we make a positive impact in

people’s lives.

For Beckman Coulter’s worldwide offi ce locations and phone numbers, please visit “Contact Us” at www.beckmancoulter.com

B2011-12240 © 2011 Beckman Coulter, Inc. PRINTED IN U.S.A.

Printed with soy ink

Space for

FSC Logo

B2011-12240_AU Reagent Quick Reference Guide_US.indd

Documents

Transcript of B2011-12240_AU Reagent Quick Reference Guide_US.indd